维普中文期刊产品整合服务
24篇 您的检索式:作者名="Hayakari"
    题名 作者 年代 出处 被引量
1Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenoos and oral administrations 显示文摘Uno T Niioka T Hayakari M 2007Eur J Clin Pharmacol2007,63,2:1
2Absolute bioavailability and metabolism of omeprazole in rela- tion to CYP2C19 genotypes following single intra- venous and oral administrations显示文摘Uno T Niioka T Hayakari M 2007Eur J Clin Pharmacol2007,63,2:1
3Absolute bioavailability and metabolism of omeprazole in relation to CYP2C 19 genotypes following single intravenous and oral administrations 显示文摘Uno T Niioka T Hayakari M 2007Eur J Clin Pharmacol2007,63,2:1
4Absolute bioavail- ability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and o- ral administrations 显示文摘Uno T Niioka T Hayakari M 2007Eur J Clin Pharmacol2007,63,2:1
5A rapid and simple spectrophotometric assay of angiotensin-converting enzyme显示文摘HAYAKARI M KONDO Y IZUMI H 1978Anal Biochem1978,84,:1
6Reduction of oxysterol levels up-regulates HMG-CoA reductase activity in rat liver显示文摘Naoki Tamasawa Makoto Hayakari Hiroshi Murakami Jun Matsui Toshihiro Suda 1997Atherosclerosis1997,,2:1
7IFN-[gamma] and TNF-[alpha] Synergistically Induce microRNA-155 Which Regulates TAB2/IP-10 Expression in Human Mesangial Cells显示文摘Imaizumi Tadaatsu Tanaka Hiroshi Tajima Atsushi Yokono Yoshikazu Matsumiya Tomoh Yoshida Hidemi Tsuruga Kazushi Aizawa-yashiro Tomomi Hayakari Ryo Inoue Ituro Ito Etsuro Satoh Kei 2010American Journal of Nephrology2010,,5:1
8Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administ rations 显示文摘Uno T Niioka T Hayakari M 2007Eur J Clin Pharmacol2007,63,:1
9Absolute bioavail- ability and metabolism of omeprazole in relation to CYP2C19 genotypes following 2 single intravenous and oral administrations显示文摘Uno T Niioka T Hayakari M 2007Eur J Clin Pharm Acol2007,63,2:1
10Edaravone and carnosic acid synergistically enhance the expression of nerve growth factor in human astrocytes under hypoxia/reoxygenation显示文摘Hidemi Yoshida Junsei Mimura Tadaatsu Imaizumi Tomoh Matsumiya Akira Ishikawa Norifumi Metoki Kunikazu Tanji Ken Ota Ryo Hayakari Kunio Kosaka Ken Itoh Kei Satoh 2011Neuroscience Research2011,,4:1
11Differentiation induc?tion of human keratinocytes by phosphatidylethanolamine-binding protein 显示文摘Yamazaki T Nakano H Hayakari M 2004J Bioi Chern2004,279,32:1
12Immune recognition of botulinum neurotoxin type A:Regions recognized by T cells and antibodies against the protective Hc fragment(residues 855-1296) of the toxin显示文摘 Hayakari M 1997Molecular Immunology1997,34,14:1
13Usefulness of glutathione S-transferase as a tumor marker显示文摘Tsuchida S Kimura J Hayakari M 1997Rinsho Byori1997,45,12:1
14Differentiation induction of human keratinocytes by phosphatidylethanolamine-binding protein 显示文摘Yamazaki T Nakano H Hayakari M 2004J Biol Chem2004,279,31:1
15Effects of Brazilian green propolis on double-stranded RNA-me-diated induction of interferon-inducible gene and inhibition of recruitment of polymorphonuclear cells显示文摘HAYAKARI R MATSUMIYA T XING F 0,,03:1
16Immune recognition of botulinum neurotoxin type A:regions recognized by T cellsand antibodies against the protective H(C) fragment(residues 855-1296) of the toxin显示文摘OSHIMA M HAYAKARI M MIDDLEBROOK J L 1997Mol Immunol1997,34,14:1
17Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species显示文摘Atassi MZ Dolimbek BZ Hayakari M 1996J Protein Chem1996,15,7:1
18Introduction of spreasheet application macros for environmental data analysis examples( 1 ) -add - in for Andersen - sampler analysis显示文摘Hayakari S Matsumoto M Saitoh K 2000Jpn SOC Atmos Environ2000,35,:1
19Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations显示文摘Uno T Niioka T Hayakari M 2007Eur J Clin Pharmacol2007,63,2:1
20Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations显示文摘Uno T Niioka T Hayakari M 2007Eur J Clin Pharrnacol2007,63,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费